Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity

被引:25
作者
Erdmann, Johannes [1 ,2 ]
Mayr, Martina [2 ]
Oppel, Ulrich [4 ]
Sypchenko, Oleg [4 ]
Wagenpfeil, Stefan [3 ]
Schusdziarra, Volker [1 ,2 ]
机构
[1] Tech Univ Munich, Else Kroner Fresenius Ctr Nutr Med, D-81675 Munich, Germany
[2] Tech Univ Munich, Dept Internal Med 2, D-81675 Munich, Germany
[3] Tech Univ Munich, Dept Med stat & Epidemiol, D-81675 Munich, Germany
[4] Univ Munich, Dept Math, Munich, Germany
关键词
Insulin secretion; Insulin-resistance; Obesity; BETA-CELL FUNCTION; PLASMA-INSULIN; C-PEPTIDE; DECREASED CLEARANCE; DOSE-RESPONSE; NORMAL HUMANS; RESISTANCE; GLUCOSE; HYPERSECRETION; INDIVIDUALS;
D O I
10.1016/j.regpep.2008.10.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is associated with insulin resistance and the resulting hyperinsulinemia has been attributed to an increase of insulin secretion and a reduction of insulin clearance. The present study was intended to further characterize the relative contribution of secretion and clearance especially in the postprandial state. In relation to WHO body weight classes 291 subjects were divided in 5 subgroups Basal insulin concentrations rose stepwise and significantly with increasing BMI. This was paralleled by C-peptide concentrations and insulin secretion, while the reduction of insulin clearance was less stringent in relation to BMI. Basal glucose was unchanged in the BM125 group and 8% higher in the obese groups (BMI 30, 35, 40) compared to normal weight (NW). Although postprandial insulin concentrations were significantly higher in the overweight and obese groups compared to NW the correlation was not as tight as in the basal state. Furthermore, the present data demonstrate for the first time that insulin secretion only increased in the overweight group without further augmentation in the obese groups. Further hyperinsulinemia of the latter was due to weight-dependent reduction of insulin clearance. The postprandial glucose response was 38-82% higher with increasing weight compared to NW. In summary basal hyperinsulinemia is mainly due to weight related increase of insulin secretion with moderate contribution of reduced insulin clearance. Postprandially, hyperinsulinemia of overweight is predominantly due to secretion while further postprandial hyperinsulinemia of obese subjects is mainly due to reduced clearance. Thus, postprandial insulin secretion cannot respond adequately to the challenge of weight-dependent insulin resistance already in non-diabetic obese subjects. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 35 条
[1]  
Balent B, 2002, ANN NY ACAD SCI, V967, P535
[2]   Fatty acids and insulin resistance [J].
Boden, G .
DIABETES CARE, 1996, 19 (04) :394-395
[3]  
BONORA E, 1984, J CLIN ENDOCR METAB, V59, P1121, DOI 10.1210/jcem-59-6-1121
[4]   PREHEPATIC INSULIN PRODUCTION IN MAN - KINETIC-ANALYSIS USING PERIPHERAL CONNECTING PEPTIDE BEHAVIOR [J].
EATON, RP ;
ALLEN, RC ;
SCHADE, DS ;
ERICKSON, KM ;
STANDEFER, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (03) :520-528
[5]   Differential association of basal and postprandial plasma ghrelin with leptin, insulin, and type 2 diabetes [J].
Erdmann, J ;
Lippl, F ;
Wagenpfeil, S ;
Schusdziarra, V .
DIABETES, 2005, 54 (05) :1371-1378
[6]   Development of hyperinsulinemia and insulin resistance during the early stage of weight gain [J].
Erdmann, Johannes ;
Kallabis, Bianca ;
Oppel, Ulrich ;
Sypchenko, Oleg ;
Wagenpfeil, Stefan ;
Schusdziarra, Volker .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 294 (03) :E568-E575
[7]  
FABER OK, 1981, J CLIN ENDOCR METAB, V53, P618, DOI 10.1210/jcem-53-3-618
[8]   β-cell function in obesity -: Effects of weight loss [J].
Ferrannini, E ;
Camastra, S ;
Gastaldelli, A ;
Sironi, AM ;
Natali, A ;
Muscelli, E ;
Mingrone, G ;
Mari, A .
DIABETES, 2004, 53 :S26-S33
[9]   Insulin resistance and hypersecretion in obesity [J].
Ferrannini, E ;
Natali, A ;
Bell, P ;
CavalloPerin, P ;
Lalic, N ;
Mingrone, G .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (05) :1166-1173
[10]  
FERRANNINI E, 1987, DIABETES METAB REV, V3, P364